RNU6-1006P

Across TCGA pan-cancer cohorts, RNU6-1006P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-1006P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-1006P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1006P expression acts as an unfavorable survival marker.

UCEC, LUSC, and LIHC are the cancer types where RNU6-1006P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	II,III,IV	0.101	0.516	.011	60	view →
LUSC	OS	Tertile	All	0.511	0.762	<.001	30	view →
LIHC	OS	Tertile	All	0.144	0.688	.013	27	view →
CESC	OS	Tertile	All	0.099	0.585	.049	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-1006P–UCEC (DFS)

Open the UCEC breakdown →